Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Showing posts with label oubreaks. Show all posts
Showing posts with label oubreaks. Show all posts

Tuesday, September 15, 2015

Medical Office Responsible For Transmitting Hepatitis C To Patients Can Reopen

SANTA BARBARA, Calif. -The Santa Barbara medical office of Dr. Allen Thomashefsky may reopen after it was shut down for unsafe injection practices.

The Public Health Department for Santa Barbara County released the following statement:
"Santa Barbara County Health Officer, Charity Dean, MD, MPH, has rescinded the Health Officer Order closing the medical office of Dr. Allen Thomashefsky. This action follows a number of measures that have been implemented to assure infection control practices are maintained at the medical office.

Genetic testing of Dr. Thomashefsky's former patients revealed at least four people who had procedures at his office the same day tested positive for Hepatitis C. A fifth may have contracted the deadly disease prior to treatment.

Read more...

Tuesday, May 5, 2015

Canada: Contaminated vial likely cause of hepatitis C outbreak: report

KITCHENER — Region of Waterloo Public Health concluded its investigation into a hepatitis C outbreak at a Kitchener colonoscopy clinic in late 2013.

The final report presented to a regional council committee Tuesday said what most likely happened is hepatitis C was spread from a previously undiagnosed client to four other patients at Tri-City Colonoscopy Clinic on Dec. 24, 2013, when a bottle of medication was contaminated.

"There was a lapse in infection control related to the use of multi-dose vials," said regional medical officer of health Dr. Liana Nolan.